Vivoryon Therapeutics N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 15 jul 2020 - 07:01
  • Statutory name Vivoryon Therapeutics N.V.
  • Title Vivoryon Therapeutics Announces Enrollment of First Patient in VIVIAD, European Phase 2b Alzheimer's Disease Study with Varoglutamstat (PQ912)

Related downloads

202007150000000001_2020-07-14_Patient Enrollment Viviad Trial_ENG_ende.pdf

Date last update: 06 July 2022

Share information

Share on: Share this